Addressing the Disease Mechanism of a Rare Kidney Disease

Marshall Fordyce, founder and CEO of Vera Therapeutics, discusses IgA nephropathy, the company’s experimental therapy atacicept, and its potential in IgAN other B cell-mediated diseases.